• Stable Yeast Expression of Exendin-4: Study Review

  2026-09-07

  Balius et al. developed recombinant expression models for Exendin-4, also known as Exenatide, in Escherichia coli and Saccharomyces cerevisiae. Chromosomally integrated yeast produced immunoreactive Exendin-4 at the expected size, providing an early synthetic-biology foundation for more accessible production while leaving bioactivity, purification, oral delivery, and therapeutic efficacy unresolved.

• Angiotensin 1/2 (1-6): An Assay-Design Guide

  2026-09-05

  Angiotensin 1/2 (1-6) is a defined Asp-Arg-Val-Tyr-Ile-His hexapeptide for resolving renin-angiotensin system biology. This guide goes beyond product description to explain fragment identity, assay controls, and the evidentiary boundaries of cardiovascular, renal, and spike-receptor research.

• Dextrose in Hypoxic Tumor Immunometabolism

  2026-09-04

  Dextrose (D-glucose) is more than a routine media ingredient: it is a controllable metabolic input for investigating how hypoxia, nutrient competition, and immune dysfunction interact in tumors. This thought-leadership article connects mechanistic findings with experimental design, product selection, and translational decision-making while defining the limits of glucose supplementation models.

• Müller Cell PEDF in Angiopoietin Retinal Survival

  2026-09-04

  The 2026 study by Younis and colleagues identifies Müller cell-derived pigment epithelium-derived factor (PEDF) as a key intermediary connecting angiopoietin signaling with retinal neuron survival. Its co-culture, hypoxia, gene-silencing, and phospho-signaling experiments distinguish the opposing effects of Ang-1 and Ang-2 and provide a framework for mechanistic retinal neurovascular assays.

• Temafloxacin: From PK to Assay Design

  2026-09-03

  Temafloxacin is a fluoroquinolone broad-spectrum antibacterial agent whose pharmacokinetic behavior can guide more interpretable antimicrobial assays. This article connects exposure, tissue distribution, renal clearance, and concentration selection to practical research decisions.

• Canagliflozin Reshapes Renal Mitochondria in Mice

  2026-09-03

  The reference study shows that canagliflozin improves proximal tubular mitochondrial architecture and bioenergetics in hypertensive–diabetic mice, with a stronger functional response in males. Its main contribution is to connect SGLT2 inhibition with renal mitochondrial remodeling and albuminuria improvement beyond glucose lowering alone.

• Docetaxel Workflows for Chemoresistance Research

  2026-09-02

  Build more informative Docetaxel assays by pairing microtubule-driven cytotoxicity with cell-cycle, apoptosis, and multidrug-resistance readouts. A renal cell carcinoma study provides a practical framework for testing how SMYD2 and miR-125b biology may alter response to Taxotere-like treatment.

• Surrogate BBB Model Improves CNS Permeability Prediction

  2026-09-02

  Hu and colleagues developed a high-throughput Transwell blood-brain barrier surrogate using LLC-PK1-MOCK and LLC-PK1-MDR1 cells, combining permeability measurements with P-glycoprotein efflux analysis and correction for lysosomal trapping. Across 41 compounds, the model correlated MDR1-derived permeability with unbound brain distribution and improved interpretation of low-recovery compounds, supporting earlier CNS candidate prioritization.

• Metformin Attenuates Vocal Fold Fibrosis via AMPK

  2026-09-01

  The reference study combines a rabbit vocal fold injury model with TGF-β1-stimulated fibroblasts to show that metformin reduces collagen deposition and fibrotic marker expression while activating AMPK. Its main contribution is a preclinical mechanistic framework linking AMPK signaling to structural preservation of the vocal fold lamina, although clinical efficacy and dose translation remain unestablished.

• Demethyleneberberine: From Metabolite to Model Design

  2026-09-01

  Demethyleneberberine is a multitarget natural alkaloid with applications spanning inflammation, neuroprotection, liver injury, and NSCLC research. This evidence-led guide shows how to translate its mechanisms into better assay selection, controls, dosing, and interpretation.

• AhR-Mediated MEHP Toxicity in Mouse Ovarian Follicles

  2026-08-31

  This study identifies the aryl hydrocarbon receptor as a functional mediator of mono(2-ethylhexyl) phthalate toxicity in mouse ovarian antral follicles. Pharmacological AhR blockade partially restored follicle growth and estrogen-related endpoints, linking phthalate exposure to altered xenobiotic signaling, steroidogenesis, and reproductive physiology.

• SIRT1–PGC-1α–TFAM Signaling in Prion-Stressed N2a Cells

  2026-08-31

  Zhao et al. show that prion protein fragment 106–126 damages mitochondria in N2a cells partly by suppressing SIRT1-dependent mitochondrial biogenesis. The study identifies the SIRT1–PGC-1α–TFAM axis as a mechanistic link between mitochondrial quality control and neuronal apoptosis, with resveratrol providing pharmacological support for this pathway.

• Canagliflozin Workflows for Renal Mitochondria

  2026-08-30

  Canagliflozin enables more than glucose-lowering experiments: it connects renal glucose transport with proximal-tubule mitochondrial structure, respiration, and albuminuria. This workflow guide shows how to build reproducible in vitro and in vivo studies while separating direct assay effects from secondary metabolic improvements.

• JXE-23 and Protective Autophagy in HCC

  2026-08-29

  A 2024 study identifies the fern-derived diterpene JXE-23 as a selective inhibitor of HepG2 hepatocellular carcinoma cell growth that produces G2/M arrest and suppresses migration. Its mechanistic contribution is the finding that JXE-23 induces protective, rather than decisively cytotoxic, autophagy through effects associated with the CIP2A/p-AKT/c-Myc axis.

• Temozolomide: A Genotype-Aware DNA Damage Tool

  2026-08-28

  Temozolomide is a small-molecule alkylating agent for modeling DNA damage, repair, and chemotherapy resistance. This article presents a genotype-aware assay framework based on ATRX-stratified glioma research, with practical guidance for interpreting combination responses.

8193 records 5/547 page Previous Next 12345 下5页 Last page